Shanghai Chicmax Cosmetic Co., Ltd. (HKG: 2145)
Hong Kong
· Delayed Price · Currency is HKD
34.75
+0.20 (0.58%)
Jan 3, 2025, 4:08 PM HKT
Shanghai Chicmax Cosmetic Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 6,106 | 4,191 | 2,675 | 3,619 | 3,382 | 2,874 |
Revenue Growth (YoY) | 103.56% | 56.64% | -26.07% | 7.02% | 17.65% | - |
Cost of Revenue | 1,529 | 1,198 | 1,009 | 1,325 | 1,253 | 1,195 |
Gross Profit | 4,577 | 2,993 | 1,666 | 2,294 | 2,129 | 1,680 |
Selling, General & Admin | 3,618 | 2,450 | 1,481 | 1,834 | 1,800 | 1,550 |
Research & Development | 149.75 | 125.81 | 110.28 | 104.75 | 77.38 | 82.89 |
Other Operating Expenses | 6.48 | 7.29 | 4.95 | 5.79 | 4.01 | 43.13 |
Operating Expenses | 3,778 | 2,568 | 1,608 | 1,951 | 1,881 | 1,676 |
Operating Income | 798.69 | 424.95 | 57.72 | 342.94 | 247.93 | 3.17 |
Interest Expense | -7.72 | -16.23 | -20.47 | -20.93 | -40.5 | -81.89 |
Interest & Investment Income | 9.37 | 9.37 | 0.81 | 0.46 | 2.13 | 1.94 |
Earnings From Equity Investments | -6.12 | -6.01 | -1.23 | -0.15 | 1.86 | 0.48 |
Currency Exchange Gain (Loss) | 1.05 | 12.8 | -4.55 | -5.15 | -5.11 | -3.36 |
Other Non Operating Income (Expenses) | 118.38 | 118.15 | 121.83 | 88.64 | 72.39 | 65.1 |
EBT Excluding Unusual Items | 913.64 | 543.03 | 154.11 | 405.8 | 278.71 | -14.55 |
Gain (Loss) on Sale of Investments | -10.39 | 16.12 | 0.08 | - | - | - |
Gain (Loss) on Sale of Assets | 0.06 | 0.06 | 0.04 | 2.33 | 0.92 | 67.47 |
Pretax Income | 903.31 | 559.21 | 154.23 | 408.12 | 279.63 | 52.92 |
Income Tax Expense | 130.16 | 97.55 | 17.15 | 69.35 | 76.44 | -6.48 |
Earnings From Continuing Operations | 773.15 | 461.66 | 137.08 | 338.77 | 203.18 | 59.4 |
Minority Interest in Earnings | -11.81 | -0.56 | 10.02 | 0.12 | 0.28 | 3.17 |
Net Income | 761.34 | 461.1 | 147.1 | 338.89 | 203.46 | 62.57 |
Net Income to Common | 761.34 | 461.1 | 147.1 | 338.89 | 203.46 | 62.57 |
Net Income Growth | 316.65% | 213.45% | -56.59% | 66.56% | 225.16% | - |
Shares Outstanding (Basic) | 398 | 398 | 361 | 360 | 360 | 360 |
Shares Outstanding (Diluted) | 398 | 398 | 361 | 360 | 360 | 360 |
Shares Change (YoY) | 4.73% | 10.22% | 0.28% | - | - | - |
EPS (Basic) | 1.91 | 1.16 | 0.41 | 0.94 | 0.57 | 0.17 |
EPS (Diluted) | 1.91 | 1.16 | 0.41 | 0.94 | 0.57 | 0.17 |
EPS Growth | 297.83% | 184.39% | -56.71% | 66.56% | 225.16% | - |
Free Cash Flow | 618.61 | 658.33 | -17.77 | 272.07 | 126.17 | -83.36 |
Free Cash Flow Per Share | 1.55 | 1.65 | -0.05 | 0.76 | 0.35 | -0.23 |
Dividend Per Share | 1.500 | 0.950 | 0.250 | 0.560 | - | - |
Dividend Growth | 233.33% | 280.00% | -55.36% | - | - | - |
Gross Margin | 74.96% | 71.41% | 62.28% | 63.38% | 62.95% | 58.44% |
Operating Margin | 13.08% | 10.14% | 2.16% | 9.48% | 7.33% | 0.11% |
Profit Margin | 12.47% | 11.00% | 5.50% | 9.36% | 6.02% | 2.18% |
Free Cash Flow Margin | 10.13% | 15.71% | -0.66% | 7.52% | 3.73% | -2.90% |
EBITDA | 869.22 | 493.54 | 123.36 | 404.7 | 296.51 | 41.71 |
EBITDA Margin | 14.23% | 11.78% | 4.61% | 11.18% | 8.77% | 1.45% |
D&A For EBITDA | 70.53 | 68.59 | 65.64 | 61.76 | 48.58 | 38.54 |
EBIT | 798.69 | 424.95 | 57.72 | 342.94 | 247.93 | 3.17 |
EBIT Margin | 13.08% | 10.14% | 2.16% | 9.48% | 7.33% | 0.11% |
Effective Tax Rate | 14.41% | 17.44% | 11.12% | 16.99% | 27.34% | - |
Source: S&P Capital IQ. Standard template. Financial Sources.